|
|
Volumn 132, Issue 1 I, 1996, Pages 23-29
|
|
Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOLIPOPROTEIN A;
APOLIPOPROTEIN B;
APOLIPOPROTEIN E;
CHOLESTEROL;
FLUNITRAZEPAM;
HEPARIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
ISOSORBIDE DINITRATE;
LIPOPROTEIN A;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NIFEDIPINE;
PENTAZOCINE;
PROBUCOL;
TRIACYLGLYCEROL;
ABDOMINAL DISCOMFORT;
ADULT;
AGED;
ANGIOCARDIOGRAPHY;
ARTICLE;
CELL PROLIFERATION;
CHOLESTEROL BLOOD LEVEL;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY OBSTRUCTION;
DRUG MECHANISM;
FEMALE;
HUMAN;
INTRACORONARY INFUSION;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESTENOSIS;
SUBLINGUAL DRUG ADMINISTRATION;
TRANSLUMINAL CORONARY ANGIOPLASTY;
VASCULAR SMOOTH MUSCLE;
|
|
EID: 0030006105
PISSN: 00028703
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-8703(96)90386-5 Document Type: Article |
|
Times cited : (66)
|
|
References (0)
|
